NCT01497561 - Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Each subject will be randomly allocated to two dose administrations out of four possible doses. Administrated subcutaneously (s.c., under the skin)

DRUG

insulin NPH

Each subject will be randomly allocated to two dose administrations out of four possible doses. Administrated subcutaneously (s.c., under the skin)

Trial Locations (1)

Novo Nordisk Investigational Site, Graz